Hyperinsulinemia in Hypertension: Associations with Race, Abdominal Obesity, and Hyperlipidemia

Archives of Family Medicine

Volumn 7, Issue 1, 1998, Pages 53-56

  Spangler, John G ^a   Bell, Ronny A ^a   Summerson, John H ^a   Konen, Joseph C ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b CAROLINAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; INSULIN; LIPID;

ADULT; AGED; ARTICLE; BLOOD; BLOOD PRESSURE; BODY CONSTITUTION; CROSS-SECTIONAL STUDY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINISM; HYPERLIPIDEMIA; HYPERTENSION; MALE; METABOLISM; MIDDLE AGED; OBESITY; RACE;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; BODY CONSTITUTION; CONTINENTAL POPULATION GROUPS; CROSS-SECTIONAL STUDIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERINSULINISM; HYPERLIPIDEMIAS; HYPERTENSION; INSULIN; LIPIDS; MALE; MIDDLE AGED; OBESITY;

EID: 0031609597     PISSN: 10633987     EISSN: None     Source Type: Journal    
DOI: 10.1001/archfami.7.1.53     Document Type: Article

References (39)

1. Kaplan NM. The deadly quartet: upper body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med. 1989;149:1514-1520.
2. Reaven G. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
3. Bönner G. Hyperinsulinemia, insulin resistance, and hypertension. J Cardiovasc Pharmacol. 1994;24(suppl 2):S39-S49.
4. Christlieb AB, Krolewski AS, Warram JH, Soeldner JS. Is insulin the link between hypertension and obesity? Hypertension. 1985;7:1154-1157.
5. Lucas CP, Estigarribia JA, Darga LL, Reaven GM. Insulin and blood pressure. Hypertension. 1985;7:702-706.
6. Manicardi V, Cannellini I, Bellodi G, Coscelli C, Ferrannini E. Evidence for an association of high blood pressure and hyperinsulinemia in obese man. J Clin Endocrinol Metab. 1986;62:1302-1304.
7. Modan M, Halkin H, Almog S, et al. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest. 1985;75:809-817.
8. McCarty MF. Insulin resistance - not hyperinsulinemia - is pathogenic in essential hypertension. Med Hypotheses. 1994;42:226-236.
9. Stout RW. Overview of the association between insulin and atherosclerosis. Metabolism. 1985;34:7-12.
10. Ducimetiére P, Eschwege E, Papoz L, Richard JL, Claude JR, Rosselin GE. Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in middle-aged population. Diabetologia. 1980; 19:205-210.
11. Eschwege E, Richard JL, Thibult N, et al. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. Horm Metab Res. 1985;15:41-47.
12. Pyörälä K. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care. 1979;2:131-141.
13. Welborn TA, Wearne K. Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diabetes Care. 1979;2:154-160.
14. Hidaka S. A study of microproteinuria among diabetic and obese subjects without clinically overt proteinuria. Nippon Jinzo Gakkai Shi. 1992;34:125-132.
15. Haaber AB, Kofoed-Enevoldsen A, Jensen T. The prevalence of hypercholesterolemia and its relationship with albuminuria in insulin-dependent diabetic patients: an epidemiological study. Diabetes Med. 1992;9:557-561.
16. Tung P, Ginier P, Levin SR, Hershman JD, Hershman JM. Clinical characteristics associated with microalbuminuria in an adult diabetic population. J Diabetes Complications. 1990;4:15-20.
17. UK Prospective Diabetes Study, IX. Relationships of urinary albumin and N-acetylglucosaminidase to glycaemia and hypertension at diagnosis of type 2 (non-insulin-dependent) diabetes mellitus and after 3 months of diet therapy. Diabetologia. 1993;36:835-842.
18. Suraniti S, Bled F, Girault A, Fressinaud P, Marre M. Serum lipids and urinary albumin excretion in non-insulin-dependent diabetics. Mol Cell Biochem. 1992; 109:197-200.
19. Haffner SM, Gonzalez C, Valdez RA, et al. Is microalbuminuria part of the prediabetic state? the Mexico City Diabetes Study. Diabetologia. 1993;36:1002-1006.
20. Summerson JH, Bell RA, Konen JC. Racial differences in the prevalence of microalbuminuria in hypertension. Am J Kidney Dis. 1995;26:577-579.
21. Rostand SG, Kirk KA, Rutsky EA, Pate BA. Racial differences in the incidence of treatment for end-stage renal disease. N Engl J Med. 1982;306:1276-1279.
22. Saad MF, Lillioja S, Nyomba BL, et al. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med. 1991;324:733-739.
23. Ferrannini E, Haffner SM, Stern MP, et al. High blood pressure and insulin resistance: influence of ethnic background. Eur J Clin Invest. 1991;21:280-287.
24. Schoenberger JA. Hypertension, lipids, and cardiovascular disease: is insulin the missing link? proceedings of asymposium. Am J Med. 1991;90(suppl2A):1S-88S.
25. Ferrannini E, Defronzo RA. The association of hypertension, diabetes, and obesity: a review. J Nephrol. 1989;1:3-15.
26. Izzo JL, Swislocki AL. Workshop III: insulin resistance: is it truly the link? Am J Med. 1991;90(suppl 4B):26S-31S.
27. Nordby G, Moan A, Kjeldsen SE, Os I. Relationship between hemorheological factors and insulin sensitivity in normotensive and hypertensive premenopausal women. Am J Hyperten. 1995;8:439-444.
28. Whitworth JA, Williamson PM, Brown MA, Colman P. Hyperinsulinemia is not a cause of cortisol-induced hyertension. Am JHypertens. 1994;7:562-565.
29. Welborn TA, Breckenridge A, Rubinstein AH, Dollery CT, Fraser TR. Serum insulin in essential hypertension and in peripheral vascular disease. Lancet. 1966; 1:1336-1337.
30. Singer P, Godicke W, Voigt S, Hajdu I, Weiss M. Postprandial hyperinsulinemia in patients with mild essential hypertension. Hypertension. 1985;7:182-186.
31. Fournier AM, Gadia MT, Kubrusly DB, Skyler JS, Sosenko JM. Blood pressure, insulin, and glycemia in nondiabetic subjects. Am J Med. 1986;80:861-864.
32. Pollare T. Insulin sensitivity and blood lipids during antihypertensive treatment with special reference to ACE inhibition. J Diabetes Complications. 1990;4:75-78.
33. Pollare T, Lithell H, Berne C. A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med. 1989;321:868-873.
34. Torlone E, Britta M, Rambotti AM, et al. Improved insulin action and glycemic control after long-term angiotensin-converting enzyme inhibition in subjects with arterial hypertension and type Il diabetes. Diabetes Care. 1993;16:1347-1355.
35. Lehtonen A. Doxazosin effects on insulin and glucose in hypertensive patients. Am Heart J. 1991;121:1307-1311.
36. Swislocki ALM, Hoffman BB, Sheu WHH, Chen I, Reaven GM. Effect of prazosin treatment on carbohydrate and lipoprotein metabolism in patients with hypertension. Am J Med. 1989;86:14-18.
37. Weinberger MH. Diuretics and their side effects: dilemma in the treatment of hy-pertension. Hypertension. 1988;11(suppl 2):16-20.
38. Frishman WH. Beta-adrenergic receptor blockers: adverse effects and drug interactions. Hypertension. 1988;11:21-29.
39. Skarfors ET, Lithell HO, Selinus I, Aber H. Do antihypertensive drugs precipitate diabetes in predisposed men? BMJ. 1989;298:1147-1151.